Loading viewer...
investor_presentation
Format: PDF investor_presentation
Beam Therapeutics presents its precision genetic medicines platform leveraging base editing technology to develop one-time, curative therapies for rare and common diseases. The presentation outlines the company's pipeline progress, including clinical trials for BEAM-101, BEAM-201, BEAM-301, and BEAM-302, alongside multiple preclinical liver programs.
brochure
investor_presentation
42 Pages
Johnson & Johnson
Münchener Rückversicherungs-Gesellschaft Investor Presentation — February 2018
investor_presentationinvestor_presentation
11 Pages
Münchener Rückversicherungs-Gesellschaft
Accelya Solutions 2022 Corporate Presentation
investor_presentationinvestor_presentation
8 Pages
Accelya Solutions India Limited